首页>
外国专利>
pharmaceutical formulation composition to treat a vaginal infection, and methods to treat a vaginal infection, to stabilize a clindamycin formulation, to treat or prevent a recurrence of a vaginal infection in a patient and to treat vaginal conditions
pharmaceutical formulation composition to treat a vaginal infection, and methods to treat a vaginal infection, to stabilize a clindamycin formulation, to treat or prevent a recurrence of a vaginal infection in a patient and to treat vaginal conditions
"PHARMACEUTICAL FORMULATION COMPOSITION TO TREAT A VAGINAL INFECTION, AND METHODS TO TREAT A VAGINAL INFECTION TO STABILIZE A CLINDAMICINE FORMULATION TO TREAT OR PREVENT A RECURRENCE OF A VAGINAL INFECTION AND A VAGINAL TRADITION A pharmaceutical formulation for treating vaginal conditions in a human patient comprises: at least one active agent; a modified release dosage form that provides sustained release of anti-infectious agent under vaginal administration to the patient; and in which the formulation, when containing a total anti-infectious agent dose of about 25 µg to about 500 mg based on the active agent, will produce a plasma concentration versus time curve (ng / mL versus hours) having an area under the curve (AUC) less than about 600 ng / mL.h.
展开▼
机译:“用于治疗阴道感染的药物配方组合物,以及用于治疗阴道感染的方法,用于稳定临床上可用于预防或预防阴道感染和阴道传统疗法的配方的药物,用于治疗人类阴道疾病的药物制剂包括:至少一种活性剂;在患者阴道给药后提供抗感染剂持续释放的改良释放剂型;其中该制剂包含的总抗感染剂剂量为约25 µg至约500 mg在活性剂上,血浆浓度随时间变化的曲线(ng / mL对小时),曲线下面积(AUC)小于约600 ng / mL.h。
展开▼